Our findings suggest the possibility that NRXN1 and NLGN1 expression and secretion in high-grade prostate tumours may modulate the activity between cancer cells and neurons, which may contribute to perineural invasion or neoneurogenesis in prostate cancer64,73,74. The gene discussed is NLGN1; the disease is prostate neoplasm.